Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Avanos Medical Q3 Adj. EPS $0.30 Beats $0.28 Estimate, Sales $171.30M Beat $169.60M Estimate

Author: Benzinga Newsdesk | November 01, 2023 07:16am

Avanos Medical (NYSE:AVNS) reported adjusted quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.28 by 7.14 percent. This is a 21.05 percent decrease over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $171.30 million which beat the analyst consensus estimate of $169.60 million by 1.00 percent. This is a 15.24 percent decrease over sales of $202.10 million the same period last year.

Posted In: AVNS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist